🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bastian von Tresckow

Essen University Hospital

ORCID: 0000-0003-1410-4487

Also affiliated with West German Heart and Vascular Center Essen

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial”.

[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial

The Lancet Oncology(2025)10.1016/s1470-2045(25)00299-2

N/A

0.434DataRank · unranked

17 citations

Manuel M Weber, Christina Laschinsky, Patrick Sandach, Timo Bartel, Alina T Küper +30 more

Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR

European Journal of Haematology(2024)10.1111/ejh.14191

N/A

0.411DataRank · unranked

8 citations

Yannick d'Hargues, Fanni Kleinert, Julia Mattlener, Jonathan Weiss, Fabian Franzen +14 more

Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial

Journal of Clinical Oncology(2025)10.1200/jco-25-00439

N/A

0.406DataRank · unranked

14 citations

Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Yon-Dschun Ko +30 more

Reply to the Letter to the Editor ‘Comments on the study of correlation between progression-free and overall survival in patients with Hodgkin lymphoma’ by Zeng et al.

Annals of Oncology(2025)10.1016/j.annonc.2025.01.013

N/A

0.104DataRank · unranked

1 citations

Bastian von Tresckow, Paul J. Bröckelmann

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)

Hematological Oncology(2021)10.1002/hon.178_2880

N/A

0DataRank · unranked

1 citations

Michael Dickinson, Joaquín Martínez‐López, Arne Kolstad, Stephen J. Schuster, Martin Dreyling +29 more